These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 15630758

  • 1. Etidronate and glucocorticoid induced osteoporosis.
    Ortego-Centeno N, Muñoz-Torres M, Callejas-Rubio JL, Riera-Montes M.
    J Rheumatol; 2005 Jan; 32(1):199-200. PubMed ID: 15630758
    [No Abstract] [Full Text] [Related]

  • 2. [Asthma--prevention of glucocorticoid-induced osteoporosis with etidronate and calcium].
    Pneumologie; 2005 Feb; 59(2):94. PubMed ID: 15724219
    [No Abstract] [Full Text] [Related]

  • 3. Preventing glucocorticoid-induced osteoporosis.
    Reid IR.
    N Engl J Med; 1997 Aug 07; 337(6):420-1. PubMed ID: 9241133
    [No Abstract] [Full Text] [Related]

  • 4. Prevention and management of glucocorticoid-induced osteoporosis.
    Lane NE, Mroczkowski PJ, Hochberg MC.
    Bull Rheum Dis; 1995 Aug 07; 44(5):1-4. PubMed ID: 7550788
    [No Abstract] [Full Text] [Related]

  • 5. Testosterone treatment of men treated with glucocorticoids.
    Odell WD.
    Arch Intern Med; 1996 Jun 10; 156(11):1133-4. PubMed ID: 8639006
    [No Abstract] [Full Text] [Related]

  • 6. Preliminary study of etidronate for prevention of corticosteroid-induced osteoporosis caused by oral glucocorticoid therapy.
    Furukawa F, Kaminaka C, Ikeda T, Kanazawa N, Yamamoto Y, Ohta C, Nishide T, Tsujioka K, Hattori M, Uede K, Hata M, Wakayama Study Group on Dermatological Use of Bisphosphonates.
    Clin Exp Dermatol; 2011 Mar 10; 36(2):165-8. PubMed ID: 20497186
    [Abstract] [Full Text] [Related]

  • 7. Corticosteroid-induced osteoporosis.
    Sambrook P.
    Aust Fam Physician; 1994 Oct 10; 23(10):1965-6. PubMed ID: 7818398
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.
    Ettinger B, Chidambaran P, Pressman A.
    Am J Manag Care; 2001 Jun 10; 7(6):597-605. PubMed ID: 11439733
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM, Valeriano J, Vasey FB, Carter JD.
    J Clin Rheumatol; 2006 Oct 10; 12(5):221-5. PubMed ID: 17023807
    [Abstract] [Full Text] [Related]

  • 10. Corticosteroid-induced bone loss.
    Millard PS.
    J Fam Pract; 1996 Apr 10; 42(4):347. PubMed ID: 8627196
    [No Abstract] [Full Text] [Related]

  • 11. Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.
    Goldstein MF, Fallon JJ, Harning R.
    Chest; 1999 Dec 10; 116(6):1733-49. PubMed ID: 10593801
    [Abstract] [Full Text] [Related]

  • 12. Prevention of glucocorticoid-induced osteoporosis: why are we doing so poorly?
    Yood RA.
    J Rheumatol; 2006 Aug 10; 33(8):1461-3. PubMed ID: 16881101
    [No Abstract] [Full Text] [Related]

  • 13. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients.
    Tałałaj M, Gradowska L, Marcinowska-Suchowierska E, Durlik M, Gaciong Z, Lao M.
    Transplant Proc; 1996 Dec 10; 28(6):3485-7. PubMed ID: 8962355
    [No Abstract] [Full Text] [Related]

  • 14. [Negative effects of steroids on bone mass. Guidelines for prevention of osteoporosis].
    Ljunghall S, Skoogh BE.
    Lakartidningen; 1994 Nov 23; 91(47):4417-9. PubMed ID: 7808153
    [No Abstract] [Full Text] [Related]

  • 15. Etidronate in the management of glucocorticoid-induced osteoporosis.
    Lukert BP.
    Am J Med; 1995 Sep 23; 99(3):233-4. PubMed ID: 7653481
    [No Abstract] [Full Text] [Related]

  • 16. Primary and secondary prophylaxis to the use of inhaled glucocorticoid in primary health care.
    Nielsen BR, Jørgensen NR, Schwarz P.
    J Asthma; 2008 Aug 23; 45(6):519-22. PubMed ID: 18612907
    [Abstract] [Full Text] [Related]

  • 17. Trends in prevention of glucocorticoid-induced osteoporosis.
    Saag KG, Gehlbach SH, Curtis JR, Youket TE, Worley K, Lange JL.
    J Rheumatol; 2006 Aug 23; 33(8):1651-7. PubMed ID: 16845707
    [Abstract] [Full Text] [Related]

  • 18. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Rossi CM, Di Comite G.
    N Engl J Med; 2008 Mar 20; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
    [No Abstract] [Full Text] [Related]

  • 19. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN.
    Minerva Med; 2008 Feb 20; 99(1):23-43. PubMed ID: 18299694
    [Abstract] [Full Text] [Related]

  • 20. How to prevent glucocorticoid-induced osteoporosis.
    Bachmeyer C, Gauthier M.
    Cleve Clin J Med; 2010 Nov 20; 77(11):762; author reply 762. PubMed ID: 21086710
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.